Sinomenine attenuates cancer-induced bone pain via suppressing microglial JAK2/STAT3 and neuronal CAMKII/CREB cascades in rat models
Shuping Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuke Tian(Tongji Hospital), Jia Sun(Union Hospital), Fei Cao(Tongji Hospital), Dawei Ye(Tongji Hospital), Ya‐Qun Zhou(Tongji Hospital), Cody Braun(Cleveland University), Fang Luo
Cited by 56
Related Papers
Interleukin-6: an emerging regulator of pathological pain
|Journal of Neuroinflammation|2016|438
Carbon Monoxide and Its Controlled Release: Therapeutic Application, Detection, and Development of Carbon Monoxide Releasing Molecules (CORMs)
|Journal of Medicinal Chemistry|2017|316
Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19
|Trends in Pharmacological Sciences|2020|304
Development and Validation of a Nomogram for Assessing Survival in Patients With COVID-19 Pneumonia
|Clinical Infectious Diseases|2020|138
PI3K/Akt Pathway: A Potential Therapeutic Target for Chronic Pain
|Current Pharmaceutical Design|2017|126